Titlebook: Genitourinary Cancers; Siamak Daneshmand,Kevin G. Chan Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Genito

aviator

U. Wollina,M. Gebhardt,D. Langeques, perioperative therapies, and postoperative management. Current management still heavily relies on pathologic staging that does not always reflect an individual patient’s risk. The genesis and progression of bladder cancer is now increasingly recognized as being a result of alterations in sever

FLINT

柱廊

腐蚀

虚弱

,Un hôpital pour la peau à Paris,rall survival of 14 months. Urothelial carcinomas harbor frequent molecular dysregulations including recurrent mutations and copy number alteration, some of which could be potential therapeutic targets. However, no molecularly targeted agents have been approved to date for the treatment of advanced

可互换

Nuklearmedizinisch-onkologische Einführungnces in surgical treatment of advanced disease has led to continued improvement in outcomes. Patients with testicular cancer who are treated following the treatment guideline mostly achieved high quality of life and long-term survival. However, patients who were identified as having non-guideline di

享乐主义者

Eulogy

https://doi.org/10.1007/978-3-319-93339-9Genitourinary Cancers; Immunotherapy; Small Renal Masses; Molecular Prognostication; Metastatic Renal Ce

Diuretic

摊位

Genitourinary Cancers978-3-319-93339-9Series ISSN 0927-3042 Series E-ISSN 2509-8497